Intrahepatic therapy for resected hepatic metastases from colorectal carcinoma

ONCOLOGY

Volumn 14, Issue 12 SUPPL. 11, 2000, Pages 48-51

  Alberts, Steven R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; OXALIPLATIN; PLATINUM COMPLEX;

CANCER STAGING; CLINICAL TRIAL; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER RESECTION; LIVER TUMOR; METASTASIS; PATHOLOGY; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; REVIEW; SURVIVAL;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE III; COLORECTAL NEOPLASMS; FLUOROURACIL; HEPATECTOMY; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; LIVER NEOPLASMS; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; RANDOMIZED CONTROLLED TRIALS; REOPERATION; SURVIVAL ANALYSIS;

EID: 0034568910     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Greenlee RT, Murray T, Bolden S, et al: Cancer statistics, 2000. CA Cancer J Clin 50:7-33, 2000.
2. Steele GD, Jr: The National Cancer Data-base report on colorectal cancer. Cancer 74:1979-1989, 1994.
3. Moertel CG, Fleming TR, MacDonald JS, et al: Levamisole and fluorouracil for adjuvant therapy of resected colon cancer. N Engl J Med 322:352-358, 1990.
4. Weiss L, Grundmann E, Torhorst J, et al: Haematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies. J Pathol 150:195-203, 1986.
5. Finan PJ, Marshall RJ, Cooper EH, et al: Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: A clinical and computer analysis. Br J Surg 72:373-377, 1985.
6. Goslin R, Steele G, Jr, Zamcheck N, et al: Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 25:749-754, 1982.
7. Bengtsson G, Carlsson G, Hafstrom L, et al: Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141:586-589, 1981.
8. Fong Y, Fortner J, Sun RL, et al: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 230:309-318, 1999.
9. Hughes K, Scheele J, Sugarbaker PH: Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am 69:339-359, 1989.
10. Ambiru S, Miyazaki M, Ito H, et al: Adjuvant regional chemotherapy after hepatic resection for colorectal metastases. Br J Surg 86:1025-1031, 1999.
11. Berlin J, Merrick HW, Smith TJ, et al: Phase II evaluation of treatment of complete resection of hepatic metastases from colorectal cancer and adjuvant hepatic arterial infusion of floxuridine: An Eastern Cooperative Oncology Group Study (PB083). Am J Clin Oncol 22:291-293, 1999.
12. Lorenz M, Muller HH, Schramm H, et al: Randomized trial of surgery vs surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 228:756-762, 1998.